An Innovative Laser Technology Dramatically Boosts Image Quality for Protein Structures

Inside every human cell, tens of thousands of proteins act as the molecular machinery of life—ferrying cargo, repairing DNA, and triggering cellular division. For decades, structural biologists have sought to map these machines atom by atom. The advent of cryo-electron microscopy (cryo-EM) revolutionized this quest, earning a Nobel Prize in 2017 for allowing scientists to visualize purified proteins frozen in vitreous ice. Yet, despite its immense power, conventional cryo-EM has hit a physical wall. It struggles to generate enough contrast to clearly image small molecules, leaving a massive blind spot in our understanding of human biology.[1][4][5]

That blind spot is now shrinking. In a landmark achievement published in Science and highlighted by Nature, researchers from UC Berkeley and Biohub have successfully integrated a "laser phase plate" into a state-of-the-art electron microscope. The device uses a continuous-wave laser, amplified to an intensity 100 million times brighter than the surface of the sun, to manipulate the electron beam. This optical intervention dramatically boosts the contrast of the resulting images, allowing scientists to resolve proteins that were previously too small or faint to see.[2][3][4][5][6][7]

The scale of the problem this solves is difficult to overstate. More than 90 percent of the proteins found inside human cells are simply too small for conventional cryo-EM to capture clearly. Currently, scientists estimate that only about 10 percent of the human proteome can be imaged in purified form, and fewer than 1 percent can be visualized in their native, crowded cellular environments. By fundamentally altering how the microscope detects biological matter, the laser phase plate promises to push that boundary, potentially making more than 50 percent of cellular proteins visible to researchers.[5]

To understand the breakthrough, one must understand the "phase problem" inherent to electron microscopy. When an electron beam passes through a biological specimen, the sample does not absorb the electrons to create a dark shadow. Biological molecules are composed of light elements like carbon, oxygen, and nitrogen, which act as "weak phase objects." Instead of blocking the electrons, the protein merely slows them down slightly, shifting the phase of their quantum wave function.[1][2][7]

Because standard detectors only measure the amplitude (intensity) of electrons, this subtle phase shift is virtually invisible. For decades, microscopists bypassed this problem by deliberately throwing the microscope out of focus. Defocusing the lens converts some of the phase shift into detectable amplitude contrast, making the protein visible. However, this optical trick comes at a steep cost: it destroys high-resolution data, blurring the finest atomic details of the molecule.[2][6][7]

The ideal solution is a physical phase plate—a device placed in the path of the electron beam that shifts the phase of the unscattered electrons by exactly 90 degrees. This perfectly converts the specimen's phase modulation into sharp amplitude contrast without requiring the lens to be defocused. Nearly a century ago, a similar concept called phase-contrast optical microscopy won a Nobel Prize for making transparent cells visible under light microscopes.[2][4][7]

Translating that concept to electron microscopes, however, proved maddeningly difficult. Previous attempts relied on thin carbon films to shift the electron phase. But when a powerful electron beam strikes a physical material, it rapidly deposits an electrostatic charge. These carbon phase plates would charge up and degrade almost instantly, rendering them unstable and largely impractical for routine, high-resolution data collection.[7]

The solution, first proposed more than 15 years ago by UC Berkeley physicist Holger Müller and biophysicist Robert Glaeser, was to replace the physical carbon film with light. Because photons do not carry an electrical charge, a laser beam cannot suffer from electrostatic charging. However, electrons and photons barely interact. To force a phase shift, the laser would need to be unimaginably intense.[5][7]

The newly unveiled system achieves this by firing a continuous-wave laser into an optical cavity consisting of highly polished, precision mirrors. The mirrors bounce the light back and forth, building a standing wave of immense power. When the electron beam passes through the focused focal point of this laser, it encounters a phenomenon known as the ponderomotive potential. The intense electromagnetic field of the laser slightly retards the electrons, shifting their phase by the crucial 90 degrees without scattering them.[4][5][6][7]

Building the device required years of engineering to overcome immense technical hurdles. A proof-of-concept was demonstrated in 2019 on an older generation microscope, but integrating the delicate optical cavity into a modern, state-of-the-art Thermo Scientific Krios cryo-EM machine required a massive collaborative effort between UC Berkeley and Biohub. The resulting instrument is one of the most complex microscopes ever constructed.[5][7]

To prove the system's efficacy, the research teams tested it on biological benchmarks. They first imaged aldolase, a medium-sized enzyme that is relatively easy for conventional machines to resolve. The laser phase plate delivered a clear improvement in resolution. But the true test was hemoglobin, the oxygen-carrying protein in red blood cells.[4][6]

At a molecular weight of just 64 kilodaltons, hemoglobin sits at the absolute lower frontier of what conventional cryo-EM can detect. It is right at the edge of the field's vision. When imaged with the new laser phase plate, the contrast of the hemoglobin molecules was dramatically enhanced, allowing the software to assemble a highly detailed 3D structure. The researchers noted that the smaller the sample, the greater the relative advantage provided by the laser.[4][5][6]

While imaging purified proteins is a massive step forward, the ultimate prize is cryo-electron tomography (cryo-ET). Cryo-ET involves tilting a flash-frozen cell and taking multiple images from different angles to compute a 3D reconstruction of the intact cellular environment. This allows scientists to see proteins not in isolation, but interacting with their neighbors inside the cell.[4][5]

Because cells are thick and complex, cryo-ET suffers from notoriously low contrast. The laser phase plate is uniquely suited to solve this. By providing in-focus phase contrast, the technology could allow researchers to map the interior of cells with unprecedented clarity, creating sub-nanometer atlases of health and disease. "To see all those interactions has been the dream of structural cell biologists for decades," noted David Agard, Biohub's Founding Scientific Director of Imaging.[2][5][6]

Despite the triumph, the technology remains in its infancy, and several uncertainties lie ahead. Single-beam laser designs can produce "ghost images"—faint, artifactual copies of high-contrast objects that can obscure delicate biological signals. Biohub is actively developing a dual-laser variant to suppress these artifacts and distribute the thermal load on the mirrors. Furthermore, scaling this bespoke, highly customized optical setup into a commercial product that can be deployed to laboratories worldwide will require significant time and industrial investment.[1][5]

Nevertheless, the successful demonstration of the laser phase plate marks a watershed moment in structural biology. By making the invisible visible, the technology promises to accelerate drug discovery, revealing the hidden molecular targets that drive cancer, neurodegeneration, and infectious diseases. As the field transitions from looking at isolated parts to observing the entire cellular engine in motion, the laser phase plate may well be the lens that brings the future of medicine into focus.[1][4][5]